Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT05346653
What this trial is testing

The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
University of Chicago 1
Testing effectiveness (Phase 2)Looking for participantsNCT06182839
What this trial is testing

Canagliflozin in Advanced Renal Disease With MRI Endpoints

Who this might be right for
ESRD, CKD Stage 4, CKD Stage 5
McGill University Health Centre/Research Institute of the McGill University Health Centre 92
Post-approval studies (Phase 4)Study completedNCT02798744
What this trial is testing

SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation.

Who this might be right for
Diabetes Mellitus, Type 2
University of Leicester 68
Testing effectiveness (Phase 2)UnknownNCT05314725
What this trial is testing

Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial

Who this might be right for
Postoperative HyperglycemiaStress Hyperglycemia
Zealand University Hospital 24
Large-scale testing (Phase 3)WithdrawnNCT07057479
What this trial is testing

Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Eurofarma Laboratorios S.A.
Post-approval studies (Phase 4)Study completedNCT05704088
What this trial is testing

SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients

Who this might be right for
SGLT2 INHIBITORSLupus NephritisBMD
Mansoura University 100
Large-scale testing (Phase 3)WithdrawnNCT04764097
What this trial is testing

Dapagliflozin Effect on Cardiovascular Outcomes in Haemodialysis for End Stage Renal Disease

Who this might be right for
Cardiovascular DiseasesEnd Stage Renal Disease
Tan Tock Seng Hospital
Post-approval studies (Phase 4)Ended earlyNCT05737186
What this trial is testing

SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency

Who this might be right for
Heart Failure With Reduced Ejection FractionRenal Insufficiency, Chronic
Peking University People's Hospital 11
Not applicableLooking for participantsNCT07237451
What this trial is testing

Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients

Who this might be right for
CKD - Chronic Kidney DiseaseHeart Failure Preserved Ejection FractionSGLT2 Inhibitors+1 more
Grigore T. Popa University of Medicine and Pharmacy 200
Post-approval studies (Phase 4)Study completedNCT03977116
What this trial is testing

Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients

Who this might be right for
Diabetes MellitusHeart FailureVentricular Arrythmia
University of Campania Luigi Vanvitelli 100
Not applicableUnknownNCT05047471
What this trial is testing

To Improve the Ability of Early Screening and Diagnosis in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Kidney Disease
Yiming Mu 10,000
Post-approval studies (Phase 4)Looking for participantsNCT07572032
What this trial is testing

Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

Who this might be right for
Heart Failure Due to Coronary Artery DiseaseValvular CardiomyopathyHeart Failure
Kyungsub Song 80
Post-approval studies (Phase 4)Looking for participantsNCT04899479
What this trial is testing

Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention

Who this might be right for
Acute Myocardial InfarctionHeart Failure
Samsung Medical Center 200
Post-approval studies (Phase 4)Study completedNCT02796170
What this trial is testing

Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesHypertension
Tulane University School of Medicine 11
Not applicableActive Not RecruitingNCT07198191
What this trial is testing

SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

Who this might be right for
Acute Myocardial Infarction (AMI)Type 2 Diabetes Mellitus (T2DM)
Yonsei University 200,000
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Not applicableStudy completedNCT05344963
What this trial is testing

Deformation Imaging by Strain in Chronic Heart Failure Over Gliflozins: an Echocardiographic Register on Sodium-GLucose coTransporter-2 Inhibitors

Who this might be right for
Sodium-GLucose coTransporter-2 InhibitorsHeart Failure With Reduced Ejection Fraction
Matteo Cameli 503
Large-scale testing (Phase 3)Looking for participantsNCT05852704
What this trial is testing

SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF

Who this might be right for
Chronic Coronary SyndromeAtrial Fibrillation
Region Örebro County 800
Post-approval studies (Phase 4)Study completedNCT05057819
What this trial is testing

Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass

Who this might be right for
Dumping SyndromeHypoglycemia, Reactive
Insel Gruppe AG, University Hospital Bern 22
Not applicableNot Yet RecruitingNCT07186153
What this trial is testing

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling in Diabetic Patients

Who this might be right for
SGLT 2 Inhibitors
Assiut University 100
Next Page